Chief Physician, Associate Professor, former Director of VIP-II Ward, Peking University Cancer Hospital Specializes in chemotherapy for digestive system malignancies, with profound expertise in comprehensive medical treatment of gastric cancer, esophageal cancer, colorectal cancer, and other conditions. Particularly experienced in multidisciplinary comprehensive treatment and clinical research for esophageal cancer, gastric cancer, and colorectal cancer. Has led multiple domestic clinical and basic research studies, participated in numerous international and domestic multicenter clinical trials, and published high-level papers in core international and domestic journals, as well as authored professional books and contributed to dozens of medical monographs. Partial Social Appointments: Chairman, Esophageal Cancer Professional Committee, Beijing Anti-Cancer Association Vice Chairman, Early Cancer Screening Professional Committee, Beijing Anti-Cancer Association Vice Chairman, Science Popularization Professional Committee, Chinese Anti-Cancer Association Member, Esophageal Cancer Professional Committee, Chinese Anti-Cancer Association Editorial Board Member, *Chinese Journal of Clinical Oncology* Editorial Board Member, *Chinese Journal of General Practitioners* Editorial Board Member, *Cancer Research and Clinic* Selected Publications: 1. X. Zhang, Z. Yan, J. Zhang, L. Gong, W. Li, J. Cui, Y. Liu, Z. Gao, J. Li, L. Shen, and Y. Lu. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. *Ann Oncol*. 2011 Oct;22(10):2257-66. 2. Zhang X1, Jia J1, Lu M2, et al. Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study. *Journal of Cancer*. 2019 Feb 23;10(6):1409-1416. 3. Ying Yang1, Peng Du2, Xiaolu Hou3, Kun Yan4, Ying Dai4, ZhiYing Sun4, Qi Wu5, Shijie Li5, Yan Yan5, Zhilong Wang6, Liping Qi6, Mailin Chen6, Hong Zheng7, Weijiao Gao7, Min Gao7, Weicheng Xue8, and Xiaodong Zhang1. Early cancer screening surveillance in one medical center of China. *PeerJ*. 2024. PMID: 39351369.